Crucial Covid vaccine data expected from Pfizer this week now unlikely to come before U.S. election


The board, which will assess whether its trial with German drugmaker BioNTech has been successful, has not conducted an interim efficacy analysis yet, Pfizer said.

Source

Leave a Reply